Skip to main content

Table 1 Effects of CRF and GABA receptor antagonists (or vehicle) on basal 5-HT release in the CeA

From: Somatosensory regulation of serotonin release in the central nucleus of the amygdala is mediated via corticotropin releasing factor and gamma-aminobutyric acid in the dorsal raphe nucleus

Treatment

Time (min)

−20 to −10

−10 to 0

0–10

10–20

20–30

30–40

40–50

50–60

α-helical CRF (icv)

99 ± 2

100

85 ± 10*

84 ± 5 **

84 ± 6 **

84 ± 7 **

85 ± 7**

83 ± 6**

Vehicle

101 ± 6

100

99 ± 5

99 ± 4

98 ± 6

100 ± 8

100 ± 7

98 ± 9

α-helical CRF (intra-DRN)

99 ± 3

100

100 ± 3

101 ± 7

93 ± 10

98 ± 5

101 ± 10

99 ± 4

Vehicle

99 ± 2

100

100 ± 1

98 ± 3

99 ± 3

96 ± 4

97 ± 2

95 ± 6

Antalarmin (intra-DRN)

100 ± 3

100

101 ± 3

100 ± 6

100 ± 8

105 ± 10

95 ± 8

99 ± 4

Vehicle

101 ± 6

100

101 ± 7

99 ± 3

100 ± 4

101 ± 2

98 ± 4

101 ± 5

ASV-30 (intra-DRN)

100 ± 7

100

101 ± 9

101 ± 4

104 ± 1

101 ± 4

107 ± 5

105 ± 6

Vehicle

103 ± 10

100

98 ± 3

99 ± 3

100 ± 8

97 ± 3

97 ± 5

99 ± 7

Bicuculline (intra-DRN)

101 ± 2

100

109 ± 12

127 ± 11**

122 ± 10**

128 ± 18**

115 ± 16

118 ± 11

Vehicle

101 ± 4

100

101 ± 3

100 ± 5

102 ± 4

98 ± 6

103 ± 14

100 ± 4

  1. 0 indicates the onset of administration. Data are expressed as a percentage (mean ± SD) of the pre-injection control value (the value obtained for baseline period of −10 to 0 min)
  2. * p < 0.05, ** p < 0.01, vs. pre-injection control values